News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Biotricity Announces the Upcoming Launch of the First-Ever Direct-to-Patient Cardiac Screening Service, Targeting the $1.05B Home Heart Health Market
Biotricity Inc. announces HeartSecure, a direct-to-consumer cardiac screening service for Americans at risk for heart disease, offering home-based solutions to improve healthcare accessibility -
-
COMMUNIQUÉ DE PRESSE
Press Release: Sanofi completes acquisition of Inhibrx, Inc.
Sanofi completes acquisition of Inhibrx, Inc., adding SAR447537 to rare disease pipeline. Former Inhibrx shareholders receive $30.00 per share in cash and one contingent value right. Inhibrx Biosciences begins trading on NASDAQ as INXB -